Jane Street’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-48,500
Closed -$553K 9097
2022
Q4
$553K Buy
+48,500
New +$719K ﹤0.01% 5948
2022
Q2
Sell
-7,600
Closed -$281K 9732
2022
Q1
$281K Buy
7,600
+700
+10% +$27.3K ﹤0.01% 8502
2021
Q4
$314K Sell
6,900
-12,900
-65% -$673K ﹤0.01% 8082
2021
Q3
$1.25M Buy
19,800
+13,300
+205% +$1.01M ﹤0.01% 5449
2021
Q2
$595K Sell
6,500
-3,200
-33% -$254K ﹤0.01% 6915
2021
Q1
$660K Buy
9,700
+2,600
+37% +$202K ﹤0.01% 6275
2020
Q4
$514K Buy
+7,100
New +$411K ﹤0.01% 5701
2020
Q3
Sell
-8,100
Closed -$287K 7179
2020
Q2
$287K Buy
+8,100
New +$231K ﹤0.01% 5905

Other funds holding CDNA

Jane Street's CDNA Position: Q1 2026 in Review

Jane Street reduced its CareDx (CDNA) stake by 42% in Q1 2026, selling an estimated $3.4M and leaving 250,351 shares worth $4.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3711.

Jane Street first reported a position in CDNA in Q3 2019 and has held it in 22 quarters since. The position peaked at $8.11M in Q4 2025. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Jane Street held 250,351 shares of CareDx worth $4.35M as of Q1 2026.
  • Jane Street sold 179,878 CareDx shares in Q1 2026, an estimated $3.4M.
  • CareDx made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3711 holding.
  • Jane Street first reported a position in CareDx in Q3 2019 and has held it in 22 quarters since.
  • Jane Street's CareDx position peaked at $8.11M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.